In Meeting with RFK Jr., CEO of Tylenol Maker Stresses There Is No Clear Link Between Medication and Autism, WSJ Reports | News Channel 3-12

In meeting with RFK Jr., CEO of Tylenol maker stresses there is no clear link between medication and autism, WSJ reports

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human Services Secretary Robert F. Kennedy Jr. privately this week in an attempt to dissuade him from including the drug as a potential cause of autism in an upcoming report, the Wall Street Journal reported Friday.

Kenvue Met With RFK Jr. in Bid to Keep Tylenol Off Autism List

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller off a list of autism-causing treatments.

CEO of Tylenol maker Kenvue lobbied RFK Jr. not to cite the drug as autism cause in upcoming report * WorldNetDaily * by WND Staff

...

Pharma Boss Pleaded With RFK Jr. to Ditch Bogus Autism Claim

The CEO of the company that makes Tylenol has directly pleaded with Robert F. Kennedy Jr. not to link the drug to autism. Kirk Perry, chief executive of Kenvue, and the company’s chief scientific officer, Caroline Tillett, met with Kennedy amid a mounting belief that his department of Health and…

CEO of Tylenol Maker Lobbied RFK Jr. Not to Cite Drug as Autism Cause in Report

(Wall Street Journal) – In a hastily scheduled meeting, Kenvue’s Kirk Perry sought to dissuade the health secretary, arguing there is no clear link The Wall Street Journal reported last week that Kennedy plans to cite the use of acetaminophen—the active ingredient in Tylenol—by pregnant women as a potential cause of autism in their children, among other potential causes. The autism report is expected from the Department of Health and Human Servi…